Stay updated on Adagrasib Combo in KRAS G12C Clinical Trial

Sign up to get notified when there's something new on the Adagrasib Combo in KRAS G12C Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Adagrasib Combo in KRAS G12C Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    New study locations were added: Liuzhou, Guangxi, China (545006) and Taoyuan, Taiwan (333); Liuchow, Guangxi, China (545006) and Taoyuan District, Taiwan (333) were removed. The page revision updated to v3.5.3.
    Difference
    0.0%
    Check dated 2026-05-05T02:09:52.000Z thumbnail image
  3. Check
    25 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-21T16:26:32.000Z thumbnail image
  4. Check
    39 days ago
    Change Detected
    Summary
    Updated the study location listing from Padua, Italy 35128 to Padova, Italy 35128.
    Difference
    0.0%
    Check dated 2026-04-07T08:22:54.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    Added new trial locations and local institutions (e.g., Florianópolis, Salvador, Viedma) with investigator contacts, and removed several existing sites; total locations updated to 764.
    Difference
    0.2%
    Check dated 2026-03-24T00:21:31.000Z thumbnail image
  6. Check
    68 days ago
    Change Detected
    Summary
    Added new study sites in Krefeld (Germany), Valledupar (Colombia), Floridablanca (Colombia), Bogotá (Colombia), and Buenos Aires (Argentina), updated site contacts, and increased total locations to 761. Montpellier-related entries and other site records were removed or corrected as part of data cleanup.
    Difference
    0.2%
    Check dated 2026-03-09T19:37:05.000Z thumbnail image
  7. Check
    85 days ago
    Change Detected
    Summary
    Added site 007-436 in Pergamino, Argentina (B2700KMP) and updated contact details for Eva-Lotte Buchmeier (site 2217) and Ullrich Graeven (site 2221). The total number of locations is now 756.
    Difference
    0.1%
    Check dated 2026-02-20T16:49:25.000Z thumbnail image

Stay in the know with updates to Adagrasib Combo in KRAS G12C Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Adagrasib Combo in KRAS G12C Clinical Trial page.